Company intelligence / Profile preview

New Wave Supply

Manchester, England, United Kingdomnewwavesupplyco.com ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

New Wave Biotech has developed an AI-driven simulation platform that enables companies in synthetic biology and alternative protein production to virtually test thousands of process scenarios. This allows users to predict output yields, costs, sustainability impacts, and optimize their processes before physical scale-up. The technology aims to reduce R&D time/costs dramatically while increasing the likelihood that new bio-manufactured products can reach commercial scale.

Modalities: fermentation-derived biologicsalternative proteinsenzymes
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on New Wave Supply.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on New Wave Supply.

Explore the full profile